Clinical Trial Update: A 6-week, Study of MG01CI Low Dose and High Dose Compared With Placebo in Adults and Adolescents With Fragile X Syndrome [Phase 2]

View source ↗

Summary

Phase 2 randomized evaluation of MG01CI at low and high doses versus placebo was conducted in adults and adolescents with Fragile X Syndrome. The study has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fragile Syndrome

Drugs mentioned

• MG01CI

Snippet

Sponsor: Alcobra Ltd. | Conditions: Fragile X Syndrome | Phase 2 | Status: COMPLETED